|
[1]
|
Sender, R., Fuchs, S. and Milo, R. (2016) Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLOS Biology, 14, e1002533. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Codagnone, M.G., Spichak, S., et al. (2019) Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease. Bio-logical Psychiatry, 85, 150-163. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sandhu, K.V., Sherwin, E., et al. (2017) Feeding the Microbiota-Gut-Brain Axis: Diet, Microbiome, and Neuropsychiatry. Translational Research, 179, 223-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sommer, F. and Bäckhed, F. (2013) The Gut Microbiota—Masters of Host Development and Physiology. Nature Reviews Microbiology, 11, 227-238. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Rhee, S.H., Pothoulakis, C. and Mayer, E.A. (2009) Principles and Clinical Implications of the Brain-Gut-Enteric Microbiota Axis. Nature Reviews Gastroenterology & Hepatology, 6, 306-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Sudo, N., Chida, Y., et al. (2004) Postnatal Microbial Colonization Programs the Hypothalamic-Pituitary-Adrenal System for Stress Response in Mice. The Journal of Physiology, 558, 263-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Erny, D., Hrabě de Angelis, A.L., et al. (2015) Host Mi-crobiota Constantly Control Maturation and Function of Microglia in the CNS. Nature Neuroscience, 18, 965-977. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sampson, T.R. and Mazmanian, S.K. (2015) Control of Brain Devel-opment, Function, and Behavior by the Microbiome. Cell Host & Microbe, 17, 565-576. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chu, C., Murdock, M.H., et al. (2019) The Microbiota Reg-ulate Neuronal Function and Fear Extinction Learning. Nature, 574, 543-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hu, X., Wang, T. and Jin, F. (2016) Alzheimer’s Disease and Gut Microbiota. Science China Life Sciences, 59, 1006-1023. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, T., Hu, X., et al. (2015) Lactobacillus Fermentum NS9 Restores the Antibiotic Induced Physiological and Psychological Abnormalities in Rats. Beneficial Microbes, 6, 707-717. [Google Scholar] [CrossRef]
|
|
[12]
|
Liang, S., Wang, T., et al. (2015) Administration of Lactobacillus helveticus NS8 Improves Behavioral, Cognitive, and Biochemical Aberrations Caused by Chronic Restraint Stress. Neuroscience, 310, 561-577. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Luo, J., Wang, T., et al. (2014) Ingestion of Lacto-bacillus Strain Reduces Anxiety and Improves Cognitive Function in the Hyperammonemia Rat. Science China Life Sciences, 57, 327-335. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tillisch, K., Labus, J., et al. (2013) Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity. Gastroenterology, 144, 1394-1401, 1401.e1-4. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Messaoudi, M., Lalonde, R., et al. (2011) Assessment of Psychotropic-Like Properties of a Probiotic Formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in Rats and Human Subjects. British Journal of Nutrition, 105, 755-764. [Google Scholar] [CrossRef]
|
|
[16]
|
Tomova, A., Husarova, V., et al. (2015) Gastrointestinal Microbiota in Children with Autism in Slovakia. Physiology & Behavior, 138, 179-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Benakis, C., Brea, D., et al. (2016) Commensal Microbiota Affects Ischemic Stroke Outcome by Regulating Intestinal γδ T Cells. Nature Medicine, 22, 516-523. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Singh, V. and Roth, S. (2016) Microbiota Dysbiosis Controls the Neu-roinflammatory Response after Stroke. Journal of Neuroscience, 36, 7428-7440. [Google Scholar] [CrossRef]
|
|
[19]
|
O’Mahony, S.M., Marchesi, J.R., et al. (2009) Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses. Biological Psychiatry, 65, 263-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jiang, H., Ling, Z., et al. (2015) Altered Fecal Microbiota Composition in Patients with Major Depressive Disorder. Brain, Behavior, and Immunity, 48, 186-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Kelly, J.R., Borre, Y., et al. (2016) Transferring the Blues: Depression-Associated Gut Microbiota Induces Neurobehavioural Changes in the Rat. Journal of Psychiatric Re-search, 82, 109-118. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Miyake, S., Kim, S., et al. (2015) Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLOS ONE, 10, e0137429. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Chen, J., Chia, N., et al. (2016) Multiple Sclerosis Patients Have a Distinct Gut Microbiota Compared to Healthy Controls. Scientific Reports, 6, Article No. 28484. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Berer, K., Gerdes, L.A., et al. (2017) Gut Microbiota from Multiple Sclerosis Patients Enables Spontaneous Autoimmune Encephalomyelitis in Mice. Proceedings of the National Academy of Sciences of the United States of America, 114, 10719-10724. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Cekanaviciute, E., Yoo, B.B., et al. (2017) Gut Bacteria from Multiple Sclerosis Patients Modulate Human T Cells and Exacerbate Symptoms in Mouse Models. Proceedings of the National Academy of Sciences of the United States of America, 114, 10713-10718. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Cheng, H., Guan, X., et al. (2019) The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story. Microorganisms, 7, Article No. 583. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yokote, H., Miyake, S., et al. (2008) NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora. The American Journal of Pathology, 173, 1714-1723. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Braniste, V., Al-Asmakh, M., et al. (2014) The Gut Microbiota Influences Blood-Brain Barrier Permeability in Mice. Science Translational Medicine, 6, 263ra158. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Koh, A., De Vadder, F., et al. (2016) From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165, 1332-1345. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Ghezzi, L., Cantoni, C., et al. (2021) Targeting the Gut to Treat Multiple Sclerosis. Journal of Clinical Investigation, 131, e143774. [Google Scholar] [CrossRef]
|
|
[31]
|
Keshavarzian, A., Green, S.J., et al. (2015) Colonic Bacterial Com-position in Parkinson’s Disease. Movement Disorders, 30, 1351-1360. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Scheperjans, F., Aho, V., et al. (2015) Gut Microbiota Are Related to Parkinson’s Disease and Clinical Phenotype. Movement Disorders, 30, 350-358. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Heintz-Buschart, A., Pandey, U., et al. (2018) The Nasal and Gut Microbiome in Parkinson’s Disease and Idiopathic Rapid Eye Movement Sleep Behavior Disorder. Movement Disorders, 33, 88-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Sun, M.F., Zhu, Y.L., et al. (2018) Neuropro-tective Effects of Fecal Microbiota Transplantation on MPTP-Induced Parkinson’s Disease Mice: Gut Microbiota, Glial Reaction and TLR4/TNF-α Signaling Pathway. Brain, Behavior, and Immunity, 70, 48-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Sampson, T.R., Debelius, J.W., et al. (2016) Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell, 167, 1469-1480.e12. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Bedarf, J.R., Hildebrand, F., et al. (2017) Functional Implica-tions of Microbial and Viral Gut Metagenome Changes in Early Stage L-DOPA-Naïve Parkinson’s Disease Patients. Genome Medicine, 9, Article No. 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Hopfner, F., Künstner, A., et al. (2017) Gut Microbiota in Parkinson Disease in a Northern German Cohort. Brain Research, 1667, 41-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Forsyth, C.B., Shannon, K.M., et al. (2011) Increased In-testinal Permeability Correlates with Sigmoid Mucosa Alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson’s Disease. PLOS ONE, 6, e28032. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Hilton, D., Stephens, M., et al. (2014) Accumulation of α-Synuclein in the Bowel of Patients in the Pre-Clinical Phase of Parkinson’s Disease. Acta Neuropathologica, 127, 235-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Holmqvist, S., Chutna, O., et al. (2014) Direct Evidence of Parkinson Pathology Spread from the Gastrointestinal Tract to the Brain in Rats. Acta Neuropathologica, 128, 805-820. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Cattaneo, A., Cattane, N., et al. (2017) Asso-ciation of Brain Amyloidosis with Pro-Inflammatory Gut Bacterial Taxa and Peripheral Inflammation Markers in Cognitively Impaired Elderly. Neurobiology of Aging, 49, 60-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Itzhaki, R.F., Lathe, R., et al. (2016) Microbes and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 51, 979-984. [Google Scholar] [CrossRef]
|
|
[43]
|
Friedland, R.P. (2015) Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration. Journal of Alzheimer’s Disease, 45, 349-362. [Google Scholar] [CrossRef]
|
|
[44]
|
Zhang, L., Wang, Y., et al. (2017) Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 60, 1241-1257. [Google Scholar] [CrossRef]
|
|
[45]
|
Dodiya, H.B., Kuntz, T. and Shaik, S.M. (2019) Sex-Specific Effects of Microbiome Perturbations on Cerebral Aβ Amyloidosis and Microglia Phenotypes. Journal of Experimental Medicine, 216, 1542-1560. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Harach, T., Marungruang, N., et al. (2017) Reduction of Abeta Amyloid Pathology in APPPS1 Transgenic Mice in the Absence of Gut Microbiota. Scientific Reports, 7, Article No. 41802. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Minter, M.R., Hinterleitner, R., et al. (2017) Antibiotic-Induced Perturbations in Microbial Diversity during Post-Natal Development Alters Amyloid Pathology in an Aged APP(SWE)/PS1(ΔE9) Murine Model of Alzheimer’s Disease. Scientific Reports, 7, Article No. 10411. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Dinan, T.G., Stanton, C. and Cryan, J.F. (2013) Psychobi-otics: A Novel Class of Psychotropic. Biological Psychiatry, 74, 720-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Schmidt, K., Cowen, P.J., et al. (2015) Prebiotic Intake Reduces the Waking Cortisol Response and Alters Emotional Bias in Healthy Volunteers. Psychopharmacology (Berlin), 232, 1793-1801. [Google Scholar] [CrossRef] [PubMed]
|